Catalys Pacific
Latest statistics and disclosures from Catalys Pacific's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MLYS, PHAT, HLVX, and represent 100.00% of Catalys Pacific's stock portfolio.
- Added to shares of these 1 stock: PHAT (+$7.2M).
- Reduced shares in these 2 stocks: MLYS (-$6.7M), HLVX.
- Catalys Pacific was a net seller of stock by $-1.1M.
- Catalys Pacific has $125M in assets under management (AUM), dropping by -5.36%.
- Central Index Key (CIK): 0002011385
Tip: Access up to 7 years of quarterly data
Positions held by Catalys Pacific consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Catalys Pacific
Catalys Pacific holds 3 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics (MLYS) | 83.5 | $105M | -5% | 8.6M | 12.11 |
|
| Phathom Pharmaceuticals (PHAT) | 16.2 | $20M | +55% | 1.1M | 18.08 |
|
| Hillevax (HLVX) | 0.3 | $416k | -80% | 236k | 1.76 |
|
Past Filings by Catalys Pacific
SEC 13F filings are viewable for Catalys Pacific going back to 2024
- Catalys Pacific 2024 Q3 filed Nov. 12, 2024
- Catalys Pacific 2024 Q2 filed Aug. 13, 2024